reac-technology
reac-technology

Post-Stroke Recovery: Optimizing Rehabilitation with REAC Neurobiological Modulation

Discover how REAC therapy accelerates post-stroke recovery. Clinical data shows this non-invasive treatment improves motor function and autonomy in less time.

  • October 15, 2025
reac-post-stroke-rehabilitation

Introduction: A New Frontier in Neuro-Rehabilitation

Stroke is a leading cause of long-term disability worldwide. The period immediately following the acute event, known as the “subacute” phase, is a critical window where the brain’s neuroplasticity is maximized, offering the greatest opportunity for functional recovery. Despite advances in conventional rehabilitation therapies, many patients do not achieve a full recovery, highlighting the need for complementary strategies that can act on central motor control mechanisms from the earliest stages.

In this context, REAC (Radio Electric Asymmetric Conveyer) technology emerges as an innovative, non-invasive approach. This article, based on the findings of a clinical study published in Cureus, explores how specific REAC neurobiological modulation protocols—namely Neuro Postural Optimization (NPO) and Neuro Muscular Optimization (NMO)—can significantly accelerate and enhance the outcomes of post-stroke rehabilitation.

The key points we will analyze include:

  • The definition of the NPO and NMO therapeutic protocols.
  • The mechanisms of action through which REAC promotes neural reorganization.
  • The clinical results achieved in patients in the subacute phase of stroke.
  • The scientific evidence supporting the efficacy of this approach.

The REAC Therapeutic Protocols: NPO and NMO

REAC technology utilizes very low-intensity, asymmetrically conveyed radioelectric fields to interact with the body’s endogenous bioelectric currents. The NPO and NMO protocols are specifically designed to act on the dysfunctional adaptive processes that occur after neurological damage.

  • Neuro Postural Optimization (NPO): This protocol consists of a single, extremely brief session lasting only a few milliseconds. Its objective is to act on neuro-psycho-motor asymmetries, promoting a rapid functional reorganization of motor circuits. An immediate and observable clinical effect is the resolution of functional dysmetria, an asymmetry in coordinated movements that indicates cerebellar-level dysfunction. NPO functions as a “neuromotor reset,” preparing the nervous system for a more effective recovery.
  • Neuro Muscular Optimization (NMO): Following the NPO treatment, the patient undergoes an intensive cycle of 10 NMO sessions, distributed over five to six days. Each session, lasting about eight minutes, aims to progressively restore neuromuscular coordination by targeting heterolateral agonist-antagonist muscle pairs. This protocol consolidates and extends the effects of NPO, helping to reinforce new motor coordination strategies.

Mechanisms of Action and Treatment Goals

The primary goal of integrating REAC treatments into early post-stroke rehabilitation is to enhance functional recovery by acting upstream—that is, on the central control circuits rather than solely on peripheral mechanisms.

The mechanism of action is based on endogenous bioelectric modulation. Unlike other neuromodulation techniques that impose an external stimulus, REAC technology acts only where dysregulations exist, helping the system regain its intrinsic capacity for self-correction. This process promotes:

  1. Rapid Neuromotor Reorganization: NPO fosters a rebalancing of cortical, subcortical, and cerebellar circuits, which are crucial for managing balance, inter-hemispheric symmetry, and movement precision.
  2. Rebalancing of Bioelectric Activity: The technology helps normalize bioelectric activity in the affected neural circuits, reducing dysfunctional motor patterns.
  3. Enhanced Neuroplasticity: By intervening in the subacute phase, REAC treatments can fully capitalize on the brain’s natural plasticity, facilitating the reorganization of sensorimotor pathways.

The synergistic integration of NPO and NMO allows for a rapid and stable effect. NPO initiates the change, while NMO consolidates it, guiding the patient toward a more robust motor recovery and autonomy.


Expected Results and Scientific Evidence

The clinical study compared a group of 13 patients treated with standard rehabilitation integrated with REAC protocols (NPO and NMO) against a historical control group of 13 patients who received only standard rehabilitation. The results were remarkable.

The REAC-treated group showed significantly greater improvements:

  • Autonomy in Activities of Daily Living (Barthel Index): The mean score increased from 33 to 68. The control group showed a more modest gain (from 36 to 67).
  • Motor Function (Fugl-Meyer Assessment – Mobility): The score improved from 9.0 to 17.3, a greater increase than that of the control group (from 8.9 to 15.3).
  • Resolution of Functional Dysmetria: In all patients in the REAC group, functional dysmetria resolved completely immediately after the single NPO session and did not recur.

Most significantly, these superior outcomes were achieved despite a shorter average length of hospital stay (30.8 days for the REAC group versus 34.4 days for the control group). This suggests that integrating REAC technology not only improves the final outcome but also accelerates the recovery process.

This data is supported by other research. For instance, a study using functional magnetic resonance imaging (fMRI) demonstrated that a single REAC pulse induces lasting changes in brain activation. Furthermore, the efficacy of REAC protocols in improving motor function has also been observed in other neurological conditions, such as post-polio syndrome and Parkinson’s disease, reinforcing the hypothesis of a central, network-level mechanism of action.


Conclusions: An Added Value for Clinical Practice

The study convincingly demonstrates the potential role of REAC neurobiological modulation, through the NPO and NMO protocols, in enhancing early functional recovery in post-stroke patients. The observed improvements in motor performance and autonomy, coupled with the rapid and stable resolution of functional dysmetria, suggest that REAC treatments act by facilitating neurofunctional reorganization and optimizing motor control circuits.

The comparative analysis with a control group reinforces the clinical relevance of these findings, particularly considering the superior recovery achieved in a shorter timeframe. This evidence supports the use of REAC neuromodulation protocols as effective and safe adjunctive tools to be integrated into comprehensive post-stroke rehabilitation pathways.

To learn more about the potential of REAC technology and discuss its integration into rehabilitation pathways, we invite you to contact our specialists for more information and scientific documentation.

Don’t miss out on the full article. Click here to continue reading!

Did you find this article interesting? Share it!

Subscribe to the newsletter

Dr. Vania Fontani

dr-vania-fontani-rinaldi-fontani-institute

Dr. Vania Fontani MD, PhD, is a prominent figure in the field of regenerative medicine and neurobiological modulation.

She has dedicated her career to research and the development of innovative technologies for human well-being.

Currently, Dr. Fontani holds the position of Scientific Director at the Rinaldi Fontani Institute in Florence, where she leads the Department of Regenerative Medicine.

In collaboration with Prof. Salvatore Rinaldi, she co-developed the REAC® (Radio Electric Asymmetric Conveyer) technology, a non-invasive methodology aimed at modulating endogenous bioelectric activity to promote health and well-being.

Her research work is documented in over 60 scientific publications, with a significant impact in the field of neuromodulation and regenerative medicine.
Her experience and expertise make her an ideal speaker for international events focused on innovation and longevity

Learn more:
• Publications: PubMed – Rinaldi S, Fontani V

Prof. Salvatore Rinaldi

dr-salvatore-rinaldi-rinaldi-fontani-institu

Physician and researcher, pioneer in neurobiological modulation, regenerative medicine, and anti-senescence therapies Scientific Director – Rinaldi Fontani Institute, Florence, Italy
ORCID: 0000-0002-8961-6316

Profile and Mission

Salvatore Rinaldi is an internationally recognized innovator for his groundbreaking
contribution to the study and clinical application of neurobiological modulation using
asymmetrically conveyed radio-electric signals (REAC). His work has redefined the
boundaries of regenerative medicine and longevity, demonstrating how optimizing
endogenous bioelectrical activity can promote cellular reprogramming, recovery of
compromised functions, and the prevention of age-related decline.

 

Research Milestones

Rinaldi’s research has opened new frontiers in the understanding and treatment of
neurodegenerative diseases and cellular aging processes. Among his most significant
contributions:


Regenerative Medicine:

  • Direct cellular reprogramming through epigenetic modulation of
    endogenous bioelectrical activity with REAC technology.
  • Radiofrequency energy loop primes cardiac, neuronal, and skeletal muscle
    differentiation in mouse embryonic stem cells: a new tool for improving tissue
    regeneration. Cell Transplant. 2012;21(6):1225-33. doi: 10.3727/096368911X600966.
  • Radio electric conveyed fields directly reprogram human dermal skin fibroblasts
    toward cardiac, neuronal, and skeletal muscle-like lineages. Cell Transplant.
    2013;22(7):1227-35. doi: 10.3727/096368912X657297.
  • Neurological morphofunctional differentiation induced by REAC technology in PC12. A
    neuro protective model for Parkinson's disease. Sci Rep. 2015 May 15:5:10439. doi:
    10.1038/srep10439.

Anti-Senescence and Longevity:

  • REAC technology and hyaluron synthase 2, an interesting network to slow down stem
    cell senescence. Sci Rep. 2016 Jun 24:6:28682. doi: 10.1038/srep28682.
  • Stem cell senescence. Effects of REAC technology on telomerase-independent and
    telomerase-dependent pathways. Sci Rep. 2014 Sep 16:4:6373. doi:
    10.1038/srep06373.
  • Anti-senescence efficacy of radio-electric asymmetric conveyer technology. Age
    (Dordr). 2014 Feb;36(1):9-20. doi: 10.1007/s11357-013-9537-8.

Neurodegenerative Diseases – Efficacy of REAC Technology in Alzheimer’s and
Neurodegeneration Models:

  • REAC technology modifies pathological neuroinflammation and motor behaviour in an
    Alzheimer's disease mouse model. Sci Rep. 2016 Oct 24:6:35719. doi:
    10.1038/srep35719.
  • Radio Electric Asymmetric Conveyer Technology Modulates Neuroinflammation in a
    Mouse Model of Neurodegeneration. Neurosci Bull. 2018 Apr;34(2):270-282. doi:
    10.1007/s12264-017-0188-0

Scientific Vision

Salvatore Rinaldi’s work demonstrates that bioelectrical modulation is not merely a
theoretical concept, but a concrete and reproducible therapeutic strategy to counteract
aging, support cellular repair processes, and prevent tissue degeneration.

Learn more:
• ORCID Profile: 0000-0002-8961-6316
• Publications: PubMed – Rinaldi S, Fontani V